glp-1 biosimilar supplements are everywhere—but do they actually work? As demand for weight-loss drugs grows, companies are cashing in on products that claim to support GLP-1 goals, often with little oversight. Tap the GLP-1 Biosimilar Delivery Systems Webinar
Description
Georgia Ede explains why meds should never be stopped abruptly, how to choose which drug to taper first, and why ultra-slow, individualized dose reductions are often safest
Research in the Journal of Nutritional Science shows curcumin directly stimulates GLP-1 secretion from intestinal L-cells

The authors take full responsibility for the content and conclusions stated in this manuscript

Instructions may vary from patient to patient and always verify your dose by checking with your provider, pharmacist, or checking the label on your medication
Epub 2009 Jun 21
Int J Dev Neurosci novembre